ArticleRSC advances2025
A zinc oxide-silver nanocomposite-based SERS nanoplatform for ultrasensitive ofloxacin determination in beef and an ophthalmic solution: effects of ZnO and ZnO content on electron transfer and SERS enhancements.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surface-Enhanced Raman Scattering (SERS) is a powerful analytical tool, which is usually based on the use of noble metal nanoparticles. To further improve the performance of SERS sensors, the substrates have been modified, leading to the design and development of metal-semiconductor nanocomposites. In this work, a series of zinc oxide-silver (ZnO/Ag) nanocomposites with different ZnO contents were prepared and employed for Raman measurements of ofloxacin (OFL) to evaluate their SERS performance. By comparing their SERS sensing performance, the effects of ZnO and ZnO content were clarified. With the most optimal ZnO content of 16 wt%, the ZnO/Ag-based SERS sensor could detect OFL at concentrations ranging from 10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.